KVUE Stock Price
Kenvue Inc.
KVUE stock price is $17.95 (+1.04% on the day), giving Kenvue Inc. a market cap of $34.00B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
KVUE Stock Overview
- Price
- $17.95
- Previous close
- $17.76
- Open
- $17.92
- Market cap
- $34.00B
- P/E ratio
- 23.1
- 52-week range
- $14.02 - $20.13
- 1-year price target
- $19.17
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- NYE
- MarketXLS Rank
- 61
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KVUE | $17.95 | +1.0% | 18.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |